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Arsenite-Mediated Promotion of Anchorage-
Independent Growth of HaCaT Cells through
Placental Growth Factor
Ichiro Yajima1,2,3, Mayuko Y. Kumasaka1,2,3, Shoko Ohnuma3, Nobutaka Ohgami1,2,3, Hisao Naito1, Hossain
U. Shekhar4, Yasuhiro Omata1 and Masashi Kato1,2,3,4
Various cancers including skin cancer are increasing in 45 million people exposed to arsenic above the World
Health Organization’s guideline value of 10mg l 1. However, there is limited information on key molecules
regulating arsenic-mediated carcinogenesis. Our fieldwork in Bangladesh demonstrated that levels of placental
growth factor (PlGF) in urine samples from residents of cancer-prone areas with arsenic-polluted drinking water
were higher than those in urine samples from residents of an area that was not polluted with arsenic. Our
experimental study in human nontumorigenic HaCaT skin keratinocytes showed that arsenite promoted
anchorage-independent growth with increased expression and secretion of PlGF, a ligand of vascular endothelial
growth factor receptor1 (VEGFR1), and increased VEGFR1/mitogen-activated protein kinase/ERK kinase (MEK)/
extracellular signal–regulated kinase (ERK) activities. The arsenite-mediated promotion of anchorage-indepen-
dent growth was strongly inhibited by PlGF depletion with decreased activities of the PlGF/VEGFR1/MEK/ERK
pathway. Moreover, arsenite proteasome-dependently degrades metal-regulatory transcription factor-1 (MTF-1)
protein, resulting in a decreased amount of MTF-1 protein binding to the PlGF promoter. MTF-1 negatively
controlled PlGF transcription in HaCaT cells, resulting in increased PlGF transcription. These results suggest that
arsenite-mediated MTF-1 degradation enhances the activity of PlGF/VEGFR1/MEK/ERK signaling, resulting in
promotion of the malignant transformation of keratinocytes. Thus, this study proposed a molecular mechanism
for arsenite-mediated development of skin cancer.
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INTRODUCTION
Inorganic arsenic, a potential carcinogen in humans, is a
common and widespread environmental contaminant for
drinking well water (National-Research-Council, 1999; IARC,
2004). In fact, tens of millions of patients with arsenicosis have
been reported in residents who drink arsenic-polluted well
drinking water in the world (National-Research-Council, 1999;
IARC, 2004). Previous epidemiological studies showed that
various cancers are increasing in patients with arsenicosis
(IARC, 1980, 2004; Smith et al., 1992; Kato et al., 2010;
Yajima et al., 2012). Cutaneous squamous cell carcinoma is
one of the representative cancers induced by arsenic
(Lansdown, 1995; IARC, 2004). However, there is limited
information on the molecular mechanism of arsenic-mediated
cancer despite its worldwide prevalence. Clinically available
molecular targets for prediction, prevention, and therapy for
arsenic-mediated cancer have not been sufficiently
established.
The HaCaT keratinocyte cell line was established from
human skin and a naturally immortalized cell line (Boukamp
et al., 1988). Morphogenesis and differentiation of HaCaT
cells are similar to those of normal keratinocyte cells in vitro
(Boukamp et al., 1988). HaCaT cells are often used to analyze
mechanisms for malignant transformation of keratinocytes
induced by environmental factors such as ultraviolet light
and heavy metals including arsenic (Kumasaka et al., 2012;
Yajima et al., 2012). On the other hand, the A431 cell line
derived from human squamous cell carcinoma is a
representative malignant keratinocytic tumor cell line (Han
et al., 2010; Yajima et al., 2012). HaCaT and A431 cells are
concurrently used to compare the characteristics of
nontumorigenic and tumorigenic cutaneous cells in vitro
(Han et al., 2010; Thang et al., 2011; Yajima et al., 2012).
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Previous studies have shown that mitogen-activated protein
kinase/ERK kinase (MEK)/extracellular signal–regulated kinase
(ERK) activation has a central role in arsenic-mediated
malignant transformation of keratinocytes (Kumasaka et al.,
2012).
Placental growth factor (PlGF) is a member of the vascular
endothelial growth factor (VEGF) family and a ligand of VEGF
receptor 1 (VEGFR1; Fischer et al., 2007; Loges et al., 2009).
Interaction of PlGF and VEGFR1 has been reported to
stimulate proliferation and invasion of tumor cells (Fischer
et al., 2007; Loges et al., 2009). PlGF messenger RNA (mRNA)
and protein levels were increased in several types of cancers
including squamous cell carcinoma (Parr et al., 2005; Cheng
et al., 2010). A phase I study using a mAb against PlGF for
SCC has already started (Martinsson-Niskanen et al., 2011;
Lassen et al., 2012). Previous studies revealed that several
transcription factors directly bind to the promoter of the PlGF
gene and regulate PlGF expression (Cramer et al., 2005;
Nishimoto et al., 2009). These results suggest that PlGF has
an important role in SCC.
Arsenic exposure through drinking well water increases the
arsenic concentration of urine in humans (Chowdhury et al.,
2000). To our knowledge, however, there is no information on
the relationships between urinary arsenic levels and urinary
PlGF levels, between urinary PlGF levels and SCC
development, and between PlGF function and arsenic-
mediated cancer.
In this study, we investigated the molecular mechanism for
arsenite-mediated anchorage-independent growth, a distinct
phenotype of cancer formation, focusing on the regulation of
PlGF expression via metal-regulatory transcription factor 1
(MTF-1) in HaCaT cells based on our fieldwork in residents of
cancer-prone areas in Bangladesh.
RESULTS
Concentrations of urinary arsenic and PlGF in residents of
Bangladesh
To elucidate the relationship between arsenic exposure and
PlGF in humans in vivo, we performed fieldwork studies in
cancer-prone areas (Samta and Tangra, Jessore; Kurokawa
et al., 2001; Yokota et al., 2002; Tareq et al., 2003)
with arsenic-polluted well drinking water (mean±SD
¼ 261.6±114.0mg l1; n¼ 15) and an unpolluted area
(Pullerhat, Jessore) with well drinking water that was not
polluted with arsenic (mean±SD¼ 2.8±5.9mg l1; n¼10)
in Bangladesh. Mean concentrations of urinary arsenic and
PlGF in residents of Samta and Tangra were 482.6mg g 1
creatinine and 33.2 pg g1 creatinine, respectively, whereas
those in residents of Pullerhat were 160.4mg g1 creatinine
and 17.7pg g 1 creatinine, respectively (Figure 1). Thus,
urinary arsenic and PlGF concentrations in residents of
cancer-prone areas were about 3- and 2-fold higher, respec-
tively, than those in residents of an arsenic-unpolluted area. As
exposure of mice to arsenic through drinking water affected
expression patterns and levels of proteins in the skin (Li et al.,
2011), we also treated hairless homozygous mice (Hr/Hr) with
30mM arsenite through drinking water for 2 months to analyze
the expression levels of PlGF protein in mouse skin
(Supplementary Figure S1 online). Immunohistochemical ana-
lysis showed that PlGF protein expression level in the epithe-
lium of arsenite-exposed mice was 2.9-fold higher than that in
control mice (Supplementary Figure S1c online). These results
suggest that arsenite exposure through drinking water increased
PlGF expression level in the epithelium mainly composed of
keratinocytes. These results also suggest that an increase of
PlGF level may be associated with arsenite exposure in
humans and mice.
Arsenite-mediated promotion of anchorage-independent growth
To reveal the relationship between arsenite exposure and
increase of PlGF level, we further examined the effect of PlGF
on arsenite-mediated development of cancer in vitro. In
previous studies, arsenic was detected in 80% of tissues of
arsenic-related keratosis and Bowen’s disease, and the max-
imum concentration was 61 800mg kg1 (824mM; Matsui
et al., 1999). Previous studies have also shown that ratios of
trivalent arsenite (As(III)) and pentavalent arsenate (As(V)) in
human urine were 13.4% and 1.5%, respectively (Hata et al.,
2012). Furthermore, arsenic concentrations in nail samples
(around 100,000mg kg1) and hair samples (10,000mg kg1)
from residents of the arsenic-polluted areas were 10- to 100-
fold higher than those in their urine (Hinwood et al., 2003;
Gault et al., 2008). Results of these previous studies suggest
that cutaneous cells in residents of arsenic-polluted areas
could be exposed to high concentrations of arsenite (As(III)).
On the other hand, more than 10mM arsenite (As(III)) was
shown to be highly toxic for human nontumorigenic normal
keratinocytes (HaCaT cells) (Boukamp et al., 1988) in our
in vitro studies, as previously shown in various kinds of cells
(Yancy et al., 2005). Therefore, 1, 3, and 10mM concentrations
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Figure 1. Levels of arsenic and PlGF in human urine samples in Bangladesh.
Concentrations (box plot) of arsenic (a) and PlGF (b) in urine samples from
residents of Samta and Tangra (n¼ 61) and Pullerhat (n¼ 40), Jessore in
Bangladesh are presented. The boxes contain 50% of all values (observations
between the 25th and 75th percentiles). The horizontal lines inside the boxes
represent the medians. The bars extend from the boxes to the highest and
lowest values. Data of urinary arsenic and PlGF were provided as creatinine-
adjusted urinary arsenic and PlGF levels. Significantly different (**Po0.01)
from concentrations of arsenic or PlGF in urine from residents of Pullerhat by
the Mann–Whitney U-test.
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of arsenite were used in our in vitro study. Although 1 and
3mM arsenite strongly promoted anchorage-independent
growth of HaCaT cells, no promotion of anchorage-
independent growth was observed in HaCaT cells treated
with 10mM arsenite (Supplementary Figure S2 online). These
results indicate that 1 and 3mM arsenite are suitable concen-
trations for examination of arsenite-mediated cancer-promot-
ing activity in nontumorigenic HaCaT cells.
Arsenite-mediated activation of PlGF expression and secretion
We then focused on PlGF as a regulatory factor for arsenite-
mediated cancer promotion. Constitutive expression level of
PlGF mRNA in A431 cells was more than 3-fold higher than
that in HaCaT cells (Figure 2a). Expression level of PlGF
mRNA in HaCaT cells was increased by treatment with 1 and
3mM arsenite for 48 h (Figure 2a). Expression level of PlGF
mRNA in HaCaT cells was about 4.0-fold increased at 3 h after
3mM arsenite stimulation (Figure 2b). More than 2.6-fold
increased expression of PlGF mRNA in HaCaT cells was still
maintained at 48 h after 3mM arsenite stimulation (Figure 2b).
Expression levels of PlGF protein in HaCaT cells were also
increased by treatment with 1 and 3mM arsenite for 48 h
(Figure 2c). We next examined the expression levels of PlGF
protein in culture medium of HaCaT and A431 cells, because
PlGF has been reported to be extracellularly secreted and to
bind to vascular endothelial growth factor receptor 1
(VEGFR1) on the cellular surface (Fischer et al., 2008).
Constitutively secreted PlGF protein level from A431 cells
cultured for 24 h was 8.7-fold higher than that from HaCaT
cells (Figure 2d), and levels of PlGF protein secreted from
cultured HaCaT cells treated with 1 and 3mM arsenite for 24 h
were 3.2- and 7.0-fold higher, respectively, than those from
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Figure 2. Arsenite-mediated expression of placental growth factor (PlGF) messenger RNA (mRNA) and protein. (a) Expression levels of PlGF mRNA evaluated by
real-time PCR in HaCaT cells untreated or treated with 1 and 3mM arsenite for 48 h (black bars) and in untreated A431 cells (a white bar) are presented. The results
are presented as ratios (mean±SD; n¼ 3) of PlGF mRNA relative to untreated HaCaT cells. (b) The time course of PlGF mRNA expression in HaCaT cells treated
with 3mM arsenite is presented. The results are presented as ratios (mean±SD; n¼3) of PlGF mRNA relative to untreated control HaCaT cells. (c) Expression levels
of PlGF protein evaluated by immunoblotting in HaCaT cells treated with 1 and 3mM arsenite for 48 h and in untreated A431 cells. Intensities of bands are
presented as ratios (mean±SD; n¼3) relative to untreated HaCaT cells. Amounts of tubulin are also presented as an internal control. (d) Amount of secreted PlGF
protein in the culture medium evaluated by ELISA is presented. Significantly different from untreated HaCaT cells (*Po 0.05; **Po0.01 in a–c), from untreated
HaCaT cells for 24 h (*Po 0.05; **Po0.01 in d) or 48 h (##Po0.01 in d) by Student’s t-test.
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untreated HaCaT cells (Figure 2d). The same results were
obtained for levels of PlGF protein secreted from HaCaT cells
cultured for 48 h (Figure 2d). These results indicated that 1 and
3mM arsenite enhances the levels of PlGF expression in, and
secretion from, HaCaT cells. In addition, expression levels of
PlGF mRNA and protein in primary normal human epithelial
keratinocyte cells were also increased by treatment with 1 and
3mM arsenite for 48 h (Supplementary Figure S3 online),
suggesting that PlGF expression is activated by arsenic
exposure in primary human keratinocyte cells, as well as a
human keratinocyte cell line.
Inhibition of arsenite-mediated anchorage-independent growth
of PlGF-depleted HaCaT cells
We next examined whether increased PlGF is involved in
anchorage-independent growth in HaCaT cells. PlGF was
depleted from HaCaT cells by small interfering RNA transfec-
tion (Figure 3a), and anchorage-independent growth of cells
treated with arsenite was examined (Figure 3b and c). Arsenite-
mediated anchorage-independent growth of PlGF-depleted
HaCaT cells was suppressed by 82.8–94.5% (Figure 3c). These
results suggest that PlGF might be a regulator for arsenite-
mediated anchorage-independent growth of HaCaT cells.
Arsenite-mediated activation of VEGFR1
As previous studies revealed that PlGF binds to VEGFR1 and
increases phosphorylated levels of VEGFR1 (Autiero et al.,
2003), we next examined the influence of arsenite on
phosphorylated levels of VEGFR1 in HaCaT cells (Figure 4a–
d). Constitutive level of VEGFR1 phosphorylation in HaCaT
cells was undetectably low, despite constitutively phosphory-
lated VEGFR1 in A431 cells (Figure 4a). Arsenite (1 and 3mM)
increased the levels of VEGFR1 phosphorylation in HaCaT
cells, whereas there were no effects of arsenite on expression
levels of VEGFR1 mRNA and protein (Figure 4a and b). In
addition, arsenite had no effect on phosphorylation and/or
expression levels of VEGFR2 and VEGFA in HaCaT cells
(Figure 4c and d).
Arsenite-mediated activation of MEK/ERK signaling
We next examined the effect of arsenite on the activation of
signal transduction molecules potentially sited downstream of
PlGF/VEGFR1 signaling. Previous studies showed that signal-
ing of activated VEGFR1 was transduced to intercellular signal
transduction including MEK/ERK, phosphoinositide 3-kinase
(PI3K)/AKT, and focal adhesion kinase (FAK) signaling path-
ways, which are associated with cancer promotion (Gille
et al., 2000; Matsumoto et al., 2002; Selvaraj et al., 2003).
Arsenite (1 and 3mM) activated the phosphorylation levels of
MEK/ERK but not PI3K/AKT and FAK signaling in HaCaT cells
(Figure 4e). Moreover, arsenite-mediated phosphorylation of
VEGFR1/MEK/ERK was suppressed in PlGF-depleted HaCaT
cells (Figure 4f).
Arsenite-mediated degradation of MTF-1 in a
proteasome-dependent manner
As our results provided evidence that arsenite-mediated
increase of PlGF could be an important trigger for promotion
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Figure 3. Inhibited anchorage-independent growth of placental growth factor
(PlGF)-depleted HaCaT cells. (a) Expression levels of PlGF protein evaluated by
immunoblotting in HaCaT cells, transfected with 25 nM of control small
interfering RNA (siRNA; siControl) or siRNA for PlGF depletion (siPlGF #1 and
#2) are presented. Amounts of tubulin are also presented as an internal control.
(b) Colonies derived from siRNA-transfected HaCaT cells untreated or treated
with 3mM arsenite and from untreated A431 cells are presented. Bar¼ 100mm.
(c) Number of colonies per well derived from siRNA-transfected HaCaT cells
(black bars) untreated or treated with 3mM arsenite and from untreated A431
cells (a white bar) are presented as ratios (mean±SD; n¼ 3) relative to untreated
HaCaT cells with siControl transfection. Significantly different from untreated
HaCaT cells with siControl transfection (**Po0.01) and from 3mM arsenite-
treated HaCaT cells with siControl transfection (##Po0.01) by Student’s t-test.
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of anchorage-independent growth, we investigated the mole-
cular mechanism for arsenite-mediated induction of PlGF
expression in HaCaT cells. Previous studies showed that
several transcription factors, including MTF-1, regulate pro-
moter activity of the PlGF gene (Nishimoto et al., 2009). As
MTF-1 is a highly conserved protein in the transcriptional
response to exposure to various elements including arsenite
(Lichtlen and Schaffner, 2001; He and Ma, 2009), we
examined the effect of arsenite on MTF-1 protein expression
in HaCaT cells. Interestingly, the amount of MTF-1 protein in
HaCaT cells treated with 3mM arsenite was significantly
decreased compared with that in untreated HaCaT cells
(Figure 5a). A proteasome inhibitor (MG-132), but not a
lysosome inhibitor (chloroquine), suppressed the arsenite-
mediated decrease of MTF-1 protein (Figure 5a). We then
performed chromatin immunoprecipitation assays to examine
the amount of MTF-1 binding to the PlGF promoter in arsenite-
treated and arsenite-untreated HaCaT cells. According to a
previous study (Nishimoto et al., 2009), a pair of primers to
amplify the 3x metal responsive element region of the PlGF
promoter was used for PCR and real-time PCR (Figure 5b and
c). Relative occupancy of MTF-1 on the PlGF promoter in
HaCaT cells treated with 3mM arsenite was less than half of
that in untreated control HaCaT cells (Figure 5c). As cadmium-
mediated degradation of Mtf-1 in a murine hepatoma cell line
(hepa1c1c7) was shown in a previous study (Bi et al., 2006),
our results suggest that arsenite induces proteasome-
dependent degradation of MTF-1, resulting in a decreased
amount of MTF-1 binding to the metal-responsive element
region of the PlGF promoter in HaCaT cells.
Increased PlGF expression in, and secretion from, MTF1-
depleted HaCaT cells
To address the biological effect of decreased expression of
MTF-1 on PlGF, we examined the levels of PlGF expression in,
and secretion from, MTF-1-depleted HaCaT cells by small
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interfering RNA transfection in the presence or absence of
3mM arsenite (Figure 6). The level of PlGF mRNA expression in
MTF-1-depleted (siMTF-1 #1 and #2) HaCaT cells was 15.4- to
16.3-fold higher than that in control (siControl) HaCaT cells
(Figure 6b). The level of PlGF protein secreted from MTF-1-
depleted HaCaT cells cultured for 48 h was 5.7- to 6.4-fold
increased compared with that from control HaCaT cells
(Figure 6c). These results suggest increased PlGF expression
and secretion levels by depletion of MTF-1 in HaCaT cells.
PlGF mRNA expression level in MTF-1-depleted HaCaT cells
treated with arsenite was further increased compared with that
in control HaCaT cells treated with arsenite (Figure 6b). Levels
of PlGF protein secreted from MTF-1-depleted HaCaT cells
treated with arsenite were slightly increased but statistically
insignificant compared with those from control HaCaT cells
treated with arsenite (Figure 6c). Thus, our results showed that
levels of PlGF expression in, and secretion from, MTF-1-
depleted HaCaT cells treated with arsenite were 28.4- to 30.1-
fold and 7.5- to 7.6-fold higher, respectively, than levels of
expression in, and secretion from, control HaCaT cells that
were not treated with arsenite (Figure 6b and c). Previous
studies showed that MTF-1 enhanced the transcription of
metallothionein IIA (MT2A) and metallothionein IG (MT1G)
genes through metal-responsive elements on their promoter
regions (Brugnera et al., 1994; Joshi et al., 2005). Induction of
arsenite-mediated MT2A expression was inhibited in MTF-1-
depleted HaCaT cells in our study (Figure 6d). MTF-1
depletion inhibited not only arsenite-mediated enhancement
of MT1G expression but also constitutive expression of MT1G
in HaCaT cells (Figure 6e).
DISCUSSION
In this study, our fieldwork demonstrated increased urinary
levels of PlGF in residents of cancer-prone areas in Bangla-
desh who drink arsenic-polluted well water. We also experi-
mentally demonstrated a unique molecular mechanism by
which arsenite-mediated degradation of MTF-1 may enhance
PlGF expression in, and secretion from, nontumorigenic
cutaneous cells, resulting in an increase of transforming
activity via activation of VEGFR1/MEK/ERK signaling
(Figure 6f). Our results suggest that arsenite exposure from
well drinking water enhances PlGF expression and secretion
via MTF-1 degradation and promotes skin cancer.
A previous study showed increased levels of PlGF expres-
sion in SCC (Cheng et al., 2010). Our fieldwork showed high
levels of urinary PlGF in residents of cancer-prone areas,
suggesting increased levels of PlGF in people at high risk for
SCC. We then experimentally showed that 1 and 3mM arsenite
increased anchorage-independent growth with enhanced
PlGF expression in, and secretion from, nontumorigenic
HaCaT cells. Arsenite-mediated activation of anchorage-
independent growth was more than 80% repressed by
depletion of PlGF in HaCaT cells. Our results also suggest
that urinary levels of PlGF might be useful for prediction of the
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transformation of keratinocytes in patients with arsenicosis,
because anchorage-independent growth is one of the
important hallmarks of transformation from normal cells to
cancer cells (Kato et al., 2002). In addition, decreased PlGF
level reduces the number of endothelial cells and
neovascularization in PlGF knockout mice (Carmeliet et al.,
2001). Monoclonal anti-Flt1 antibody MF1 (anti-Flt1), which
blocked binding of VEGF and PlGF to Flt1, inhibited growth
and angiogenesis of tumors derived from A431 cells
subcutaneously injected into nude mice (Luttun et al., 2002).
Therefore, PlGF may also be associated with angiogenesis in
arsenite-induced skin cancer.
HaCaT cells have compound heterozygous mutations in
each p53 allele that show decrease of protein activities
(Lehman et al., 1993). Wild-type p53 (WT-p53) is associated
with apoptosis, and downregulation of p53 activity is an
important step in the progression of cancer, including SCC
(Brash, 2006). The role of WT-p53 in arsenite-induced
anchorage-independent growth of HaCaT cells was analyzed
by using transfection of a WT-p53 expression vector into
HaCaT cells (Supplementary Figure S4 online). Ectopic expres-
sion of Halo-tag-fused WT-p53 was detected at 86 kDa
(Supplementary Figure S4a online), and it increased the
expression level of p21Cip1/WAF1, a direct target of p53 and a
tumor-suppressor gene (Abbas and Dutta, 2009; Supple-
mentary Figure S4b online). Anchorage-independent growth
was observed in HaCaT cells ectopically expressing WT-p53
and GFP for tracing transfected cells treated with 3mM arsenite
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Figure 6. Expression levels of placental growth factor (PlGF), MT2A, and MT1G in metal-regulatory transcription factor-1 (MTF-1)-depleted HaCaT cells treated
with arsenite. (a) Expression levels of MTF-1 protein evaluated by immunoblotting in HaCaT cells, transfected with 25 nM control small interfering RNA (siRNA;
siControl) or siRNA for MTF-1 depletion (siMTF-1 #1 and #2), are presented. Amounts of tubulin are also presented as an internal control. (b) Expression levels of
PlGF messenger RNA (mRNA) evaluated by real-time PCR in siRNA-transfected HaCaT cells untreated or treated with 3mM arsenite are presented. The results are
presented as ratios (mean±SD; n¼ 3) of PlGF mRNA relative to HaCaT cells untreated with arsenite. (c) Amounts of secreted PlGF protein evaluated by ELISA in
culture medium of HaCaT cells, transfected with 25 nM of control siRNA (siControl) or siRNA for MTF-1 depletion (siMTF-1 #1 and #2), in the absence or presence
of 3mM arsenite are presented. Expression levels of MT2A (d) and MT1G (e) mRNAs evaluated by real-time PCR in HaCaT cells transfected with 25 nM control
siRNA (siControl) or siRNA for MTF-1 depletion (siMTF1 #1 and #2) untreated or treated with 3mM arsenite are presented. The results are presented as ratios
(mean±SD; n¼ 3) of MT2A and MT1G mRNA relative to HaCaT cells transfected with 25 nM control siRNA (siControl). Significantly different from untreated
HaCaT cells with siControl transfection (**Po0.01 in b–e), from untreated HaCaT cells with siMTF-1 #1 transfection (#Po0.05 in b) or with siMTF-1 #2
transfection (yPo0.05 in b) and from 3mM arsenite-treated HaCaT cells with siControl transfection (#Po0.05 in c) by Student’s t-test. NS, not significant. (f) Our
proposal for the potential pathway of arsenite-mediated transformation in HaCaT cells is presented as a schema.
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(Supplementary Figure S4i and j online). Levels of anchorage-
independent growth of WT-p53-transfected HaCaT cells trea-
ted with 3mM arsenite were significantly lower than those in
empty vector–transfected HaCaT cells treated with 3mM
arsenite (Supplementary Figure S4k online). These results
suggest that HaCaT cells expressing WT-p53 are not only
viable but also show an increased level of anchorage-inde-
pendent growth under the condition of treatment with 3mM
arsenite.
We further analyzed the molecular mechanism of PlGF
for arsenite-mediated cancer promotion in HaCaT cells.
Since we found that arsenite increased VEGFR1 activity
without affecting VEGFR1 expression, arsenite may have
enhanced VEGFR1 activity by increasing PlGF secretion.
Although PlGF does not directly bind to VEGFR2, PlGF
affects phosphorylation and/or expression of VEGFA and
VEGFR2 through intermolecular cross talk of activated
VEGFR1 (Roy et al., 2005). Therefore, we next examined
whether arsenite affects phosphorylated and/or expression
levels of VEGFR2 and VEGFA. The results showed that there
was no expression of VEGFR2 and very limited effects of
arsenite on phosphorylated and/or expression levels of
VEGFR2 and VEGFA in HaCaT cells. Our results suggest
that VEGFR1 activation through arsenite-mediated increase
of PlGF expression and release enhanced activities of MEK/
ERK but not those of PI3K/AKT and FAK (Figure 6f).
We finally analyzed the molecular mechanism of
arsenite-mediated enhancement of PlGF expression. Pre-
vious studies showed that MTF-1 acted as a positive
regulator for PlGF expression in human embryonic kidney
HEK293 cells and human choriocarcinoma BeWo cells
under a hypoxia condition (Cramer et al., 2005;
Nishimoto et al., 2009). Therefore, we assumed that
arsenite-mediated increase of MTF-1 would enhance PlGF
expression in HaCaT cells. However, contrary results were
obtained in this study. Arsenite induced proteasome-
dependent degradation of MTF-1 protein, resulting in a
decreased level of MTF-1 binding to the PlGF promoter and
enhanced levels of PlGF expression in, and secretion from,
HaCaT cells. These results suggest that the mechanism of
MTF-1-mediated regulation of PlGF expression in HaCaT
cells might be different from that in HEK293 and BeWo
cells. On the other hand, expression of MT2A and MT1G,
other target genes of MTF-1 (Brugnera et al., 1994; Joshi
et al., 2005), was inhibited in MTF-1-depleted HaCaT cells.
Thus, MTF-1-mediated positive regulation for MT2A and
MT1G mRNA expression in HaCaT cells corresponds to the
results of previous studies (Brugnera et al., 1994; Joshi
et al., 2005). MTF-1 might exhibit different functions in
different genes and cells and with different environmental
stimulations. The reason why MTF-1 acts as a negative
regulator for PlGF expression in HaCaT cells remains
unknown. A recent study showed that the N-terminal
domain of MTF-1, which includes a nuclear import and
export signaling sequence and a zinc finger domain,
inhibits its own transcriptional activity (He and Ma,
2009). The results of that study also suggested that the
N-terminal domain of MTF-1 interacted with a repressor
protein, resulting in the inhibition of transcription of its
target genes (He and Ma, 2009). Moreover, levels of
anchorage-independent growth were decreased in PlGF-
depleted A431 cells, whereas levels of PlGF expression
were increased in MTF-1-depleted A431 cells (Supple-
mentary Figure S5 online). These results suggest that the
same mechanism of increased levels of anchorage-inde-
pendent growth through increase of PlGF expression
mediated by MTF-1 downregulation is involved in both
HaCaT and A431 cells.
In conclusion, results of our studies may have provided an
insight into the role of PlGF in arsenite-mediated skin cancer
in vitro. Further study should be carried out to determine
whether PlGF is useful for the prevention of arsenite-mediated
skin cancer.
MATERIALS AND METHODS
Measurements of arsenic in well water and measurements of
urinary arsenic and PlGF
Samples of well drinking water (n¼ 15) and human urine (n¼ 61)
were collected in Samta and Tangra, previously reported cancer-
prone areas, Jessore in Bangladesh (Kurokawa et al., 2001; Yokota
et al., 2002; Tareq et al., 2003). Details are described in Supple-
mentary Informationonline.
Reagents
See Supplementary Information online.
Cell culture
HaCaT and A431 cells were supplied from Cell Line Service (Eppelheim,
Germany) and RIKEN BioResource Center (Tsukuba, Japan), respectively.
Details are described in Supplementary Information online.
Colony-formation assay
Cells (2 104) were added to 1 ml of 1.5% methylcellulose/DMEM
and treated or not treated with arsenite in 24-well culture plates with
Ultra-low attachment surfaces (Corning, NY). Details are described in
Supplementary Informationonline.
Real-time PCR
Total RNA was prepared from culture cells using a High Pure
RNA Purification Kit (Roche, Basel, Switzerland) according to the
manufacturers’ protocol. Details are described in Supplementary
Information online.
Immunoblotting
See Supplementary Information online.
RNA interference
Small interfering RNA–mediated depletion (knockdown) of
PlGF and MTF-1 was performed with nucleotide synthetic duplexes
(Invitrogen, MA). Details are described in Supplementary Information
online.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assay was performed by using a
Simple ChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology,
MA). Details are described in Supplementary Information online.
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Mice and exposure to arsenite and immunohistochemistry
Hairless homozygous mice (Hr/Hr) at 4 weeks of age were used for
exposure experiments (n¼ 5 in each concentration of arsenite).
Details are described in Supplementary Information online.
Transfection of expression vectors
See Supplementary Information online.
Statistics
The SPSS (version 18) software package (IBM, NY) was used
for statistical analyses by Student’s t-test and the Mann–Whitney
U-test.
Ethics statement
Sampling in Bangladesh was ethically approved by the Ethics
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